Lateral flow assays (LFAs), such as the COVID-19 rapid test, are powerful devices to rapidly detect a protein’s presence or absence. This assay is so easy to perform that it enables at-home testing, ...
In addition, it has high sensitivity and specificity, ensuring accuracy despite requiring only a low sample volume and little or no samples or reagent preparations. Amerigo Scientific’s nucleic acid ...
In health care, paper-based diagnostics have revolutionized point-of-care approaches by providing disposable, low-cost tools that can be used remotely. Developed by the World Health Organization (WHO) ...
The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
NEW YORK, NY and SAN DIEGO, CA, July 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aegea Biotechnologies, Inc. (“Aegea”) ( www.aegeabiotech.com),a biotechnology company focused on the development ...
HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care ("POC") diagnostic tests for infectious ...
As the omicron variant has created a new wave of cases around the country, a corresponding appetite for COVID testing has emerged as well. As has been the case with so much of the pandemic, there's a ...
Amerigo Scientific’s nucleic acid lateral flow strips are rapid, point-of-care, lateral-flow-format diagnostic assays, designed to detect biotin and FITC/FAM labeled amplicon. One of its featured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback